Research  >  Labs & groups  >  Neuropsychopharmacology  >  About the neuropsychopharmacology research group
Share:  
|
PAGE
MENU

About the neuropsychopharmacology research group

Neuropsychopharmacology group

Our research looks at neuropsychiatric symptoms associated with illness, which include mood changes, apathy, aggression and cognitive changes. These are common sequelae, or consequences, of many central nervous system disorders, such as dementia, traumatic brain injury, cerebrovascular disease and stroke.

Our lab focuses on:

  • the underlying neurobiology of neuropsychiatric symptoms
  • examining predictors of response
  • using novel drugs or repurposing existing drugs for new indications
  • identifying and managing modifiable risk factors to prevent cognitive decline.

Interested in memory research news? Subscribe to our newsletter!

Investigators

Dr. Krista Lanctôt
view profile

Dr. Nathan Herrmann
view profile

Dr. Damien Gallagher
view profile

Dr. Mark Rapoport
view profile

Dr. Giovanni Marotta